Adoptive_Cell_Therapy

In 2021, adoptive cell therapy (ACT) research reached a new high. See other ACT trends over the past five years.

Related resources

ASGCT Citeline Q3 2023 Report_resource-card-thumbnail
OCT 01, 2023
レポート
商業化支援サービス

Gene, Cell, + RNA Therapy Landscape Q3 2023 Report

Q3 2023 saw 3,866 therapies in development; 53% of those were gene therapies, 25% RNA therapies, and 22% non-genetically modified cell therapies.

Clinical-resource-ISCT Report_resource-card-thumbnail
JUN 01, 2023
レポート
研究開発支援サービス

Cell and Gene Therapy Global Regulatory Report

The first Cell and Gene Therapy Regulatory Report from Citeline and ISCT provides a global overview of the cell and gene therapy landscape.

ESMO congress event logo held in Madrid 2023.
OCT 01, 2023
ニュース記事
研究開発支援サービス

ESMO 2023 Insights

In this overview, we look at the clinical trial landscape for trials that had data presented at ESMO 2023.